By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003



Drug Discovery

Company News
Achillion (ACHN) Reports Third Quarter And Nine Month 2015 Financial Results 11/6/2015 7:13:33 AM
Achillion (ACHN) Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society of Hematology Detailing Novel Results With Factor D Inhibitors 11/5/2015 8:43:03 AM
Achillion (ACHN) To Present At The Credit Suisse 24th Annual Healthcare Conference 11/2/2015 7:57:32 AM
Achillion (ACHN) Announces That Janssen Pharmaceutical Has Initiated A Phase IIa Study To Evaluate The Combination Of AL-335, Odalasvir (ACH-3102), And Simeprevir For The Treatment Of Genotype 1 Chronic HCV 10/16/2015 7:43:41 AM
Gilead (GILD) Rumored to be Eying Achillion (ACHN)...Again 8/17/2015 5:50:01 AM
Achillion (ACHN) Reports Second Quarter And Six Month 2015 Financial Results 8/10/2015 10:14:28 AM
Achillion (ACHN), Johnson & Johnson (JNJ) Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead (GILD) and AbbVie (ABBV) 5/19/2015 3:42:55 PM
Janssen Enters Into A Worldwide Collaboration With Achillion (ACHN) To Combat Hepatitis C Virus 5/19/2015 12:50:11 PM
Twitter Attempts to Marry Gilead (GILD), Achillion (ACHN), Finds Reality Instead 5/19/2015 7:23:20 AM
Achillion (ACHN) Reports First Quarter 2015 Financial Results 5/7/2015 12:40:44 PM